Equillium (EQ) Current Deferred Revenue (2022 - 2024)

Equillium (EQ) has 3 years of Current Deferred Revenue data on file, last reported at $2.1 million in Q3 2024.

• Current Deferred Revenue for Q3 2024 came in at $2.1 million, down 86.94% year-over-year; the trailing twelve-month figure through Sep 2024 was $2.1 million (down 86.94% YoY), and the FY2023 annual result was $15.7 million, up 7.0% from the prior year.
• Current Deferred Revenue retreated to $2.1 million in Q3 2024 per EQ's latest filing, from $8.4 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $15.8 million in Q3 2023 and troughed at $2.1 million in Q3 2024.
• A 3-year average of $12.4 million and a median of $14.5 million in 2022 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue grew 7.0% in 2023, then sank 86.94% in 2024.
• A 3-year view of Current Deferred Revenue shows it stood at $14.7 million in 2022, then gained by 7.0% to $15.7 million in 2023, then slumped by 86.85% to $2.1 million in 2024.
• Business Quant data shows EQ's Current Deferred Revenue at $2.1 million in Q3 2024, $8.4 million in Q2 2024, and $13.4 million in Q1 2024.